| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.11. | Mental Health Care Was Never Built for Everyone - AI Won't Fix That | ||
| 02.11. | Midstream Health Snags $20M to Provide Health Systems More Financial Stability | ||
| 01.11. | Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic | ||
| 01.11. | MMI Raises $125M to Expand Robotic Microsurgery and Explore New Treatments | ||
| 01.11. | What the Midterms Mean for Healthcare and the Investors Betting on It | ||
| 01.11. | Prestige Is a Business Model | ||
| 30.10. | Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs | ||
| 30.10. | Bambusa IPO Brings In $169M to Break Immunology's 'Therapeutic Ceiling' | ||
| 30.10. | It's A TRAP! Employer Concerns for Tuition Reimbursement and Other Employee Repayment Agreements | ||
| 30.10. | A Meaningful Signal on Palliative Care - But Not Yet a Benefit | ||
| 29.10. | What's Driving the Rise of Consumer Diagnostics? | ||
| 29.10. | BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting Fabry Drug | ||
| 29.10. | Beyond a Score: Putting The Patient Experience at the Heart of OCD Innovation | ||
| 29.10. | 3 Ways ProgenyHealth Can Transform Maternity and Infant Health, Claims Management | ||
| 29.10. | Senators Investigate Insurers' Role in Removing Thousands from ACA Coverage | ||
| 28.10. | Eli Lilly's 'Triple-G' Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial | ||
| 28.10. | Ahead of Midterms, HFMA Calls for Cross-Sector Action on Healthcare Affordability | ||
| 28.10. | Work Requirements Put New Pressure On Medicaid Member Retention | ||
| 28.10. | How Can Hospitals and Pharmacists Collaborate on Effective Stewardship Programs for Opioids and Antibiotics? | ||
| 27.10. | Willow Acquires 2 Women's Health Companies | ||
| 27.10. | Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva | ||
| 27.10. | ClarityCare Raises $16.5M to Speed Up Prior Authorizations | ||
| 27.10. | A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals | ||
| 27.10. | How Experts Are Reacting to Trump's Women's Health Executive Order | ||
| 26.10. | Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3 |